ADIPOQ and lipodystrophy: This finding is unexpected, as lipodystrophy resulting from adipose-tissue-specific ablation of PPARγ (PPARγ-FKO) or the insulin receptor (IR-FKO) using the Adiponectin-Cre line both result in severe metabolic dysfunction [29], [30].